Navigation Links
Roskamp Institute Wins Grant for Lung Cancer Research
Date:6/10/2008

James & Esther King Biomedical Research Program Awards Peer-Reviewed Grant

SARASOTA, Fla., June 10 /PRNewswire/ -- The Roskamp Institute (Roskamp) today announced it was awarded the Florida Department of Health and James & Esther King Biomedical Research Program, Small Business Technology Transfer Grant for its advanced cancer research in using B-amyloid protein to stop the growth of lung cancer.

The grant in the amount of $100,000 was awarded to Roskamp's Investigator Daniel Paris, Ph.D. based on the scientific merit score Roskamp's proposal received through a competitive and qualified peer review process and the consideration of other factors by the Biomedical Research Advisory Council.

"This grant brings us one step closer to stopping the growth of lung cancer through our continued research with the use of B-amyloid protein," said Paris. "We are excited to have been awarded this grant, and we look forward to the advances we intend to make through our Institute's anti-cancer technology."

The peer-reviewed grant given to Roskamp for the "Treatment of Lung Adenocarcinoma and Metastasis by Anti-angiogenic Fragments of Abeta" project commences on July 1, 2008, and the life of the grant will be overseen by a grant manager of the James & Esther King Biomedical Research Program.

"The James & Esther King Program is known for its highly competitive grant award process, and we are honored to be a recipient," said Dr. Michael Mullan, director of Roskamp. "As a member of Florida's research community, we are committed to using this collaborative opportunity with small biomedical businesses and researchers alike to further our research advancements in hopes of curing this devastating disease."

The Roskamp Institute is a not-for-profit research Institute located in Sarasota and Tampa, Florida, that is dedicated to understanding the causes of, and finding cures for, neuropsychiatric and neurodegenerative disorders and addictions with an emphasis on Alzheimer's disease. Roskamp's Memory Centers also offer comprehensive cognitive and medical assessment toward differential diagnosis of Alzheimer's disease and offers treatments and disease management options once the diagnostic evaluation is complete.

For more information, please contact the Roskamp Institute in Sarasota at (941) 752-2949, the Roskamp Institute Clinical Trials Division in Sarasota at (941) 256-8018, the Roskamp Institute Memory Center in Tampa at (813) 979-2008, or visit us online at http://www.RoskampInstitute.com.


'/>"/>
SOURCE Roskamp Institute
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
2. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
3. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
4. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
5. Solazyme Selected for National Institute of Standards and Technology Award
6. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
7. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
8. National Institutes of Health Awards $25.5M Contract to SRA
9. The USC Stevens Institute for Innovation Opens Shop on US Health Sciences Campus
10. Infectious Disease Research Institute Receives Grant for Acquisition of Core Research Equipment from M.J. Murdock Charitable Trust
11. The USC Stevens Institute for Innovation Opens Shop on USC Health Sciences Campus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Research and Markets has announced the addition of Jain ... to their offering. ... , This report describes different ... as proteomics and metabolomics. Molecular diagnostics technologies are used for the ... Currently the most important applications of biomarkers are in ...
(Date:12/5/2016)... According to the new ... (Consumable, Instruments, Automated Cell Expansion System), Cells Types ... Research, Cancer, and Cell-Based Research), End-users (Biopharmaceutical and ... Revenue, Trends, Growth, Share, Size and Forecast to ... cell expansion market is expected to reach USD ...
(Date:12/5/2016)... , Dec. 5, 2016 NxGen MDx announced today that it ... test in house, we,ve been able to improve customer service through shortened ... says Alan Mack , CEO of NxGen MDx. ... , , A decrease ... has led to more job opportunities at the Grand Rapid headquarters. ...
(Date:12/5/2016)... , December 5, 2016 ... worldwide, with almost $108 billion of revenue and some ... billion were spent on global biopharmaceuticals, and this figure ... morning, Stock-Callers.com has lined up these four equities for ... ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ), Acorda ...
Breaking Biology Technology:
(Date:6/16/2016)... The global Biometric ... USD 1.83 billion by 2024, according to a ... proliferation and increasing demand in commercial buildings, consumer ... the market growth.      (Logo: ... of advanced multimodal techniques for biometric authentication and ...
(Date:6/9/2016)... 9, 2016  Perkotek an innovation leader in attendance control systems is proud to ... hours, for employers to make sure the right employees are actually signing in, and ... ... ... ...
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
Breaking Biology News(10 mins):